Analysis of the trend of pharmaceutical business transformation under the new medical reform

In the face of the new medical environment under the new medical reform, it is predicted that the next three years will be a three-year change in the pattern of the pharmaceutical industry, and the future development trend of pharmaceutical business companies will no longer be adaptable with changes in the medical environment. Adjustment. The development trend of pharmaceutical commercial companies will be classified and developed in different directions according to their own advantages. As far as the overall trend is concerned, with the increase in the openness and transparency of pharmaceutical information, especially market and price information, the market for pharmaceutical marketing has been deepened and refined, and the functions of pharmaceutical commercial companies have become weaker and weaker. The preconditions are becoming less and less. Commercial companies that are mainly based on the transfer of traditional pharmaceutical and commercial companies have realized that their distribution share is shrinking, and the transferred profits have become almost unprofitable. The transition period of pharmaceutical and commercial companies has arrived. On the contrary, the pure marketing ability of pharmaceutical commercial companies is gradually replacing its ability to allocate and become the core competitiveness of commercial companies in the future medical environment. Pharmaceutical commercial companies have also begun to develop in different directions around their pure marketing capabilities and pure sales characteristics.

The direction and mode of development of future pharmaceutical commercial companies can be classified and analyzed by our classification of pharmaceutical commercial companies. At present, according to the terminal sales characteristics of pharmaceutical commercial companies, they can be divided into three categories: one is distribution-type pharmaceutical business; the other is terminal sales promotion-type pharmaceutical business; the third is distribution and terminal promotion-type pharmaceutical business.

First, we analyze the current status and future development trends of distribution-type pharmaceutical businesses. The distribution-type pharmaceutical business can be divided into three categories. * It is a pharmaceutical business company mainly based on hospital channel distribution. It is the designated distribution business for the drug bidding for hospital drugs, and the sales channels are mainly hospital distribution. At present, it is a mainstream commercial company in its major regional markets, such as Zhejiang Yingte Pharmaceutical Co., Ltd. and Xi'an Shuanghe Pharmaceutical Co., Ltd. The second is a pharmaceutical commercial company mainly engaged in the distribution of retail pharmacies and third terminal channels. It relies on its complete logistics system of drug distribution, logistics, warehousing and distribution, and regionally distributed distribution capacity to occupy the retail market of regional market drugs. Its survival and development are more market-oriented. For example: Kyushu Tong Pharmaceutical Business across the country. The third is the distribution-type pharmaceutical business in the hospital and retail markets, and the third terminal market. Currently, this type of pharmaceutical business company is a mainstream pharmaceutical business company with strong regional market, such as Beijing Pharmaceutical, Guangzhou Pharmaceutical, and Chongqing Pharmaceutical. For example, Chongqing Pharmaceutical Co., Ltd., which is a subsidiary of Chongqing Pharmaceutical Co., Ltd., has a number of specialized medical and commercial companies, including Chongqing Pinghe Logistics Co., Ltd., which mainly sells in retail, wholesale and third terminal markets. The main pharmaceutical companies, medical and trade centers and other branches, there are professional chain of health care products in the OTC market.

Secondly, from the development trend of future distribution-type pharmaceutical commercial companies, the overall scale development and the establishment of a refined terminal segmentation distribution system are the development trend of such pharmaceutical commercial companies, and the core is still firmly grasping the terminal market. Distribution rights, the acquisition of the right to distribute the drugs in the hospital market is the threshold for entering the market, and the means is its large-scale market effect. Only when the scale is expanded, can it attract more upstream businesses, with complete varieties and specifications. Based on the premise of reasonable price, establish and improve the excellent service distribution system, continuously strengthen the pharmaceutical market's own market competitiveness, expand the market coverage and distribution capacity, enhance the overall sales scale of the enterprise and gradually strengthen the monopoly position of the enterprise regional market, and strengthen the enterprise. Profitability level. Therefore, the future distribution-type pharmaceutical commercial company is the development trend of the pharmaceutical business that has initially formed a strong distribution status in the regional market. The key point of development is to further expand the scale of enterprise distribution and gradually consolidate the strong distribution service capability of the regional market until the monopoly position. Attracting the support and other marketing activities of upstream suppliers, and making full use of the financial strength and scale effect of the company, and constantly merging and merging small and medium-sized pharmaceutical commercial companies in the blind spot area to form the sharing of upstream resources and market resources. To increase the overall market size effect of pharmaceutical commercial companies, which is the development trend of large-scale pharmaceutical business in the regional market.

Proteins are large biomolecules, or macromolecules, consisting of one or more long chains of amino acid residues. Proteins perform a vast array of functions within living organisms, including DNA replication, catalyzing metabolic reactions, responding to stimuli, and transporting molecules from one location to another.